PTC Therapeutics
PTCT
#2687
Rank
HK$48.28 B
Marketcap
HK$601.40
Share price
-0.76%
Change (1 day)
59.68%
Change (1 year)

PTC Therapeutics (PTCT) - Cash on Hand

Cash on Hand as of September 2025 : HK$13.13 Billion

According to PTC Therapeutics 's latest financial reports the company has HK$13.13 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

PTC Therapeutics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$8.84 B29.22%
2023-12-31HK$6.84 B113.38%
2022-12-31HK$3.20 B-46.79%
2021-12-31HK$6.03 B-29.52%
2020-12-31HK$8.55 B60.01%
2019-12-31HK$5.34 B200.02%
2018-12-31HK$1.78 B19.28%
2017-12-31HK$1.49 B-16.83%
2016-12-31HK$1.79 B-31.61%
2015-12-31HK$2.62 B7.43%
2014-12-31HK$2.44 B121.33%
2013-12-31HK$1.10 B5128.92%
2012-12-31HK$21.12 M-90.43%
2011-12-31HK$0.22 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Vertex Pharmaceuticals
VRTX
HK$48.94 B 272.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$6.62 B-49.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.67 B-87.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
HK$14.60 B 11.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$3.66 B-72.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$75.92 B 477.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland